A retrospective, safety and efficacy, pilot study of mirabegron for the treatment of neurogenic bladder in pediatric patients with spina bifida
Latest Information Update: 04 Mar 2020
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 04 Mar 2020 New trial record